Of on a little dash, lets see how it test $1.25.
A lot of talk on CNBC last night about M&A in the sector, mostly Pharama buying up Biotech's at a cheap price.
Then there was the big Roche/Genetech deal. Probably not our ball park in terms of size(unfortunatley) but evidence of M&A in the sector.